INDIA LIVE DESKNIFTY 50:23,140.50(+0.34%)SENSEX:73,895.74(+0.43%)
RDU Global
๐Ÿ‡ฎ๐Ÿ‡ณ
Home/Topics/Companies & Institutions/Jubilant Ingrevia
Back to Newsroom
๐ŸขOrganization Dossier

Jubilant Ingrevia

Curated news coverage, institutional background, regulatory filings, and investigative reporting across RDU Global.

3 Stories Indexed
Last Updated: Just Now
Verified Entity Intelligence
Macro Economy & Fiscal Policy 07 Nov 2026, 02:00 PM IST

Kotak Neo Flags Seven Diwali Picks With Up to 75% Upside as Indiaโ€™s Growth Story Holds Firm

Kotak Neo has identified seven stocks that it believes could deliver meaningful upside, ranging from moderate gains in large-cap names to as much as 72.5% in Jubilant Ingrevia, against a backdrop of Indiaโ€™s resilient macroeconomic outlook. The list reflects a mix of earnings visibility, valuation comfort and sector-specific growth drivers, with APL Apollo Tubes and Eternal among the names singled out for stronger medium-term potential.

By RDU Global Wire6 min read
Markets, IPOs & Wealth13 Oct 2026, 03:23 AM IST

Quant Mutual Fund Sells Rs 190 Crore Jubilant Pharmova Stake as Abakkus Steps In; Company Clears Rs 800 Crore Debt-Raising Plan

Quant Mutual Fund has pared a significant holding in Jubilant Pharmova through bulk deals, selling 20.81 lakh shares worth Rs 190.47 crore, while Abakkus Four2Eight Opportunities Fund acquired 11 lakh shares in the same trading window. The transactions came as the pharmaceutical company approved plans to raise up to Rs 800 crore through non-convertible debentures and sought broader authorisation for debt issuance, underscoring active capital-market positioning around the stock.

6 min readRead โ†’
Markets, IPOs & Wealth12 Oct 2026, 11:38 PM IST

Quant Mutual Fund Sells Rs 190 Crore Jubilant Pharmova Stake as Company Lines Up Rs 800 Crore Fundraise

Quant Mutual Fund has pared its holding in Jubilant Pharmova through a block deal worth Rs 190.47 crore, selling 20.81 lakh shares even as Abakkus Four2Eight Opportunities Fund stepped in to buy 11 lakh shares. The transaction comes at a sensitive moment for the pharmaceutical company, which has approved plans to raise up to Rs 800 crore via non-convertible debentures and is seeking broader authorisation for debt issuance.

4 min readRead โ†’

๐Ÿข About this Entity

Corporations, startups, regulatory bodies, central banks, ministries and judicial courts. All news mentioning this entity is automatically verified and aggregated into this live intelligence dossier.

Co-Occurring Entities

Entities frequently referenced alongside Jubilant Ingrevia: